🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2024-519382-22-00
Completed Phase I

A research study of a new medicine, NNC9733-0001, in healthy participants and participants with type 2 diabetes

2024-519382-22-00 · tracked via the Priya Life Science EU tracker
Sponsor
Novo Nordisk A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Nutritional and Metabolic Diseases
Decision date
24/10/2025
Enrollment target
72
Sites
Germany

Condition studied

Healthy Participants and Participants with type 2 diabetes

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2024-519382-22-00 on CTIS ↗ ← All trials in the EU